- Home
- SUIG vs VOR Comparison
SUIG vs VOR Comparison
Compare SUIG & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUIG
- VOR
- Stock Information
- Founded
- SUIG 2006
- VOR 2015
- Country
- SUIG United States
- VOR United States
- Employees
- SUIG N/A
- VOR N/A
- Industry
- SUIG Finance Companies
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- SUIG Finance
- VOR Health Care
- Exchange
- SUIG Nasdaq
- VOR Nasdaq
- Market Cap
- SUIG 250.4M
- VOR 207.1M
- IPO Year
- SUIG N/A
- VOR 2021
- Fundamental
- Price
- SUIG $3.30
- VOR $26.93
- Analyst Decision
- SUIG Strong Buy
- VOR Buy
- Analyst Count
- SUIG 2
- VOR 6
- Target Price
- SUIG $5.75
- VOR $85.33
- AVG Volume (30 Days)
- SUIG 1.6M
- VOR 456.3K
- Earning Date
- SUIG 11-11-2025
- VOR 11-07-2025
- Dividend Yield
- SUIG N/A
- VOR N/A
- EPS Growth
- SUIG 619.34
- VOR N/A
- EPS
- SUIG 0.24
- VOR N/A
- Revenue
- SUIG $3,305,884.00
- VOR N/A
- Revenue This Year
- SUIG N/A
- VOR N/A
- Revenue Next Year
- SUIG N/A
- VOR N/A
- P/E Ratio
- SUIG $13.92
- VOR N/A
- Revenue Growth
- SUIG 1.77
- VOR N/A
- 52 Week Low
- SUIG $1.13
- VOR $2.62
- 52 Week High
- SUIG $8.66
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- SUIG N/A
- VOR 47.62
- Support Level
- SUIG N/A
- VOR $26.01
- Resistance Level
- SUIG N/A
- VOR $28.31
- Average True Range (ATR)
- SUIG 0.00
- VOR 2.28
- MACD
- SUIG 0.00
- VOR -1.35
- Stochastic Oscillator
- SUIG 0.00
- VOR 16.56
About SUIG Sui Group Holdings Limited Common Stock
Sui Group Holdings Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.